PRA Health Sciences Files for Initial Public Offering

Published on: 

Applied Clinical Trials

PRA Health Sciences announced that it has filed a registration statement with the US Securities and Exchange Commission

PRA Health Sciences announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to a proposed initial public offering (“IPO”) of shares of its common stock by PRA Health Sciences. The number of shares to be offered and the price range has not yet been determined.

Read the full release here.